A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer. [electronic resource]
Producer: 20100817Description: 1020-6 p. digitalISSN:- 1569-8041
- Adenocarcinoma -- drug therapy
- Aged
- Aged, 80 and over
- Carcinoembryonic Antigen -- blood
- Colorectal Neoplasms -- drug therapy
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Humans
- Indoles -- therapeutic use
- L-Lactate Dehydrogenase -- blood
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Prognosis
- Protein Kinase C -- antagonists & inhibitors
- Protein Kinase C beta
- Tissue Distribution
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.